Skip to main content


The National Institutes of Health (NIH) campuses host a variety of events that inform, challenge, and unite the biomedical research community. IRP investigators lead or participate in many of these events, and they regularly present their work at scientific conferences at the NIH and around the world. We invite you to learn about (and possibly join us in) some of our upcoming events. Unless otherwise noted, times listed are Eastern Standard Time (EST).

Monday, May 23, 2016, 3:00 pm to 4:00 pm

Lipsett Amphitheatre, NIH Clinical Center (Bldg 10)

Next up in the NCI CCR Eminent Lecture Series is “Oncogene Addiction” by Dean W. Felsher, M.D., Ph.D., Stanford University School of Medicine. Felsher’s laboratory investigates how oncogenes initiate and sustain tumorigenesis. We have developed model systems whereby we can conditionally activate oncogenes in normal human and mouse cells in tissue culture or in specific tissues of transgenic mice.

Wednesday, May 25, 2016, 1:30 pm

Lipsett Amphitheater, NIH Clinical Center (Bldg 10)

NIAAA is pleased to announce that Marlene Oscar Berman, Ph.D., will deliver the 8th Annual Jack Mendelson Honorary Lecture. Dr. Berman’s lecture is titled, “Brain Mechanisms Underlying the Perceptual, Emotional, and Cognitive Impairments Associated with Chronic Alcohol Use Disorder.” The Jack Mendelson Honorary Lecture is free and open to the public.

Marlene Oscar Berman, Ph.D., is Professor of Neurology, Psychiatry, and Anatomy & Neurobiology at Boston University School of Medicine and Research Scientist in the Department of Veterans Affairs Healthcare System.

Through her more than 40 years as a researcher and educator, Dr. Berman has advanced our understanding of the brain mechanisms underlying the perceptual, emotional, and cognitive impairments associated with chronic alcohol use disorder (AUD). Her research addresses abnormalities in brain circuits controlling emotional perception and regulation and the impact of brain damage on the course of AUD development. One of her many seminal contributions was to characterize the syndrome of severe amnesia for events occurring after the onset of extensive brain damage produced by alcoholism, known as Korsakoff’s syndrome.

Currently, Dr. Berman uses neurobehavioral tests and neuroimaging measures of brain structure and function to assess how emotional dysregulation may underlie addiction problems like AUD. She also explores how AUD-related abnormalities in the brain circuits that control emotional perception and regulation may differ for men and women. These differences can directly affect how people make economic, social, and health-related decisions, such as whether to continue to drink.

Dr. Berman has published approximately 250 peer-reviewed manuscripts, invited reviews, and book chapters. She is also a dedicated mentor who has formally mentored more than 60 graduate students, post-docs, and students on their way to medical or graduate school.

About the Lecture Series:
As a tribute to Dr. Jack Mendelson's remarkable contributions to the field of clinical alcohol research, the National Institute on Alcohol Abuse and Alcoholism established the Jack Mendelson Honorary Lecture Series.
Each spring, the series features a lecture by an outstanding alcohol investigator whose clinical research makes a substantial contribution to our understanding of alcoholism susceptibility, alcohol's effects on the brain and other organs, and the prevention and treatment of alcohol use disorders. Learn more at

Sign language interpreters will be provided. For other reasonable accommodations or further information call Joanna Mayo at 301-443-3860. For TTY callers, please call the above number through the Federal Relay Service at 1-800-877-8339.

Wednesday, May 25, 2016, 3:00 pm to 4:00 pm (reception to follow)

Masur Auditorium, NIH Clinical Center (Bldg 10) 3:00–4:00 p.m.

Join us for WALS. This week's lecture is “Bacteria as master regulators and aphrodisiacs” by Nicole King, Ph.D., professor of molecular and cell biology at the University of California, Berkeley.

About the speaker: Nicole King studies the closest living relatives of animals—the choanoflagellates—to reconstruct animal origins and elucidate core mechanisms underlying animal cell and developmental biology.  More than six hundred million years ago, an unusual group of microbial eukaryotes evolved the capacity for complex multicellularity and eventually spawned the full diversity of modern animals. Because modern animal development and physiology (including in humans) depend upon ancient mechanisms for cell adhesion and intercellular signaling, understanding animal origins promises to help illuminate modern animal development, homeostasis, and disease. To reconstruct the genetic, cell biological, and developmental foundations of animal origins, King’s lab studies the closest living relatives of animals, the choanoflagellates. They are particularly focused on understanding the biology of the choanoflagellate Salpingoeca rosetta, which is capable of alternating between single-celled and multicelled morphologies in response to a signaling molecule produced by environmental bacteria.  Although first described in 1847, choanoflagellates passed much of the following 150-plus years in obscurity. Thus, in addition to their goal of reconstructing animal origins, the lab has been developing choanoflagellates into experimentally tractable model organisms for studies of molecular mechanisms.

Come join your colleagues, DDIR Michael Gottesman and NIH Director Francis Collins at these top-notch lectures, even if you think they are outside of your area of interest. The Wednesday Afternoon Lecture Series is this highest-profile scientific lecture series at the NIH, created to keep the NIH community informed of the latest world-class science. Speakers are nominated by NIH scientific staff.  Receptions with the speaker supported by our lecture partner, FAES, follow each lecture. The next next WALS talk is May 26 (yes, the next day, a Thursday), “Tailored drug release surfaces for regenerative medicine and targeted nanotherapies,” by Paula T. Hammond, Ph.D., Massachusetts Institute of Technology. The full 2015–2016 schedule is posted at

Thursday, May 26, 2016, 3:00 pm to 4:00 pm (reception to follow)

Masur Auditorium, NIH Clinical Center (Bldg 10)

Paula Hammond, Ph.D., of MIT will deliver the rescheduled annual WALS—Margaret Pittman Lecture, “Tailored drug release surfaces for regenerative medicine and targeted nanotherapies”. Hammond is the David H. Koch Chair Professor of Engineering in the Chemical Engineering Department at the Massachusetts Institute of Technology and a member of MIT’s Koch Institute for Integrative Cancer Research. The core of her work is the use of electrostatics and other complementary interactions to generate functional polymer materials with highly controlled architecture. Her research in nanotechnology encompasses the development of new biomaterials to enable drug delivery from surfaces with spatio-temporal control. She also investigates novel responsive polymer architectures for targeted nanoparticle drug and gene delivery, and self-assembled materials systems for regenerative medicine.

Lecture abstract: Alternating electrostatic assembly is a tool that makes it possible to create ultrathin film coatings that contain highly controlled quantities of one or more therapeutic molecules within a singular construct. These release systems greatly exceed the usual ranges of traditional degradable polymers. The nature of the layering process enables the incorporation of different drugs within different regions of the thin film architecture; the result is an ability to uniquely tailor both the independent-release profiles and order-of-release of each therapeutic to the targeted region of the body. The Hammond lab has demonstrated the use of this approach to release or present signaling molecules such as growth factors and small interfering RNA (siRNA) and DNA to regulate genes to facilitate tissue regeneration in situ for orthopedic implants, address soft-tissue wound healing, deliver vaccines from microneedle surfaces, or administer targeted nanotherapies that are highly synergistic for cancer treatments.

Come join your colleagues, DDIR Michael Gottesman and NIH Director Francis Collins at these top-notch lectures, even if you think they are outside of your area of interest. The Wednesday Afternoon Lecture Series is this highest-profile scientific lecture series at the NIH, created to keep the NIH community informed of the latest world-class science. Speakers are nominated by NIH scientific staff. Receptions with the speaker supported by our lecture partner, FAES, follow each lecture. The full 2015–2016 schedule is posted at

Tuesday, May 31, 2016 to Wednesday, June 1, 2016

Natcher Conference Center (Bldg 45)

Titled “Innovative Models and Methods,” the 2016 NIH Pain Consortium Symposium will highlight advances in pain research including lessons learned in translational research and bridging the gap between models and the clinic. The first keynote address, titled “Challenges of Translational Pain Research: What Makes a Good Model?” will be delivered by David J. Clark, M.D., Ph.D., Stanford University. The second keynote address will be delivered by Rob Gereau, Ph.D., Washington University, “New Technologies in Translational Pain Research.” A poster session will include a broad selection of current pain research findings presented by junior investigators. Members of the extramural scientific community, the NIH scientific community, health care providers, and the public are invited to attend. The event is free and open to the public. View agenda and register online at The symposium will be videocast live at

Thursday, June 2, 2016 to Friday, June 3, 2016

Natcher Conference Center (Bldg 45)

Sickle Cell in Focus (SCiF) is an annual two-day intensive and educational conference co-hosted by the National Heart, Lung and Blood Institutes (NHLBI) in Washington, DC and the South Thames Sickle Cell & Thalassaemia Network (STSTN) in London, UK. It highlights and discusses the emerging clinical complications and clinical management of sickle cell disease. The clinical and scientific research lectures are aimed at an audience of consultants, academics, trainee doctors and health professionals involved in the care of patients with the disease. It attracts local, national and international guest speakers and delegates.

There is no fee for registration. For those traveling from outside the immediate area, hotel reservations are suggested at the Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814.

Friday, June 3, 2016, 12:00 pm to 1:00 pm

Wilson Hall (Bldg 1), 3rd Floor

Join us as Deborah Citrin, M.D., of NCI presents "Novel concepts in radiation-induced normal tissue injury" as part of the 2015-2016 Director’s Seminar Series. The speakers of this series are stellar, recently tenured Senior Investigators. For queries, please contact the Office of Intramural Research, OD, NIH at (301) 496-1921.

Thursday, June 9, 2016

Natcher Conference Center, Bldg 45

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) Point-of-Care Technology Research Network (POCTRN) symposium and will focus on point-of-care technologies and their clinical translation to address challenges in quality healthcare. The POCTRN was created by the NIBIB in 2007 to drive the development of appropriate point-of-care diagnostic technologies through collaborative efforts that merge scientific and technological capabilities with clinical need. This symposium will highlight posters and presentations by guest speakers and POCTRN centers’ scientists about point-of-care technology with the focus on “Co-Inventing the Future Through Collaboration.” The keynote speaker is Stefanie Akselrod, who will deliver the talk “Bringing a POC Test to the US Market-FDA Perspective.” During the symposium there will be over 30 electronic poster presentations and demonstrations that were the result of projects supported by POCTRN. Point-of-Care researchers, clinicians, sponsoring agencies and foundations are invited to attend. Register at